Methanol Toxicity Workup

  • Author: Kalyani Korabathina, MD; Chief Editor: Tarakad S Ramachandran, MBBS, FRCP(C), FACP   more...
 
Updated: Feb 3, 2012
 

Approach Considerations

Renal profile

Significant methanol ingestion leads to metabolic acidosis, which is manifested by a low serum bicarbonate level. The anion gap is increased secondary to high lactate and ketone levels. This is probably due to formic acid accumulation.[12, 13]

Serum osmolarity

Methanol ingestion results in an elevated osmolar gap, so in cases of stupor of unknown cause, testing for an osmolar gap should be routine. However, the osmolar gap is a nonspecific finding because it may represent the presence of a low ̶ molecular weight solute, such as ethanol, other alcohols, mannitol, glycine, lipids, or proteins.

The osmolar gap can be calculated using a set formula. To find the osmolar gap, take the measured plasma osmolality and subtract the calculated osmolality. Calculated osmolality requires a serum glucose measurement and is derived as follows:

Calculated osmolality (mOsm/kg) = 2(Na+) + (glucose/18) + (blood urea nitrogen [BUN]/2.8)

Serum amylase

Hemorrhagic pancreatitis has been described in as many as two thirds of the patients with methanol poisoning.

Serum methanol

Definitive diagnosis of methanol toxicity requires a confirmed increase in the serum methanol level with gas chromatography. Peak levels are achieved 60-90 minutes after ingestion, but they do not correlate with the level of toxicity and thus are not a good indicator of prognosis.

Electroretinography/visual evoked response

Two cases of methanol toxicity were evaluated using these studies. Characteristic findings correlated well with pathologic results and postulated toxicity. Loss of retinal sensitivity was coupled with scotomata in both patients evaluated. In addition, decreased amplitudes were found on visual evoked-response testing, although latencies were normal.[14]

Next

CT Scanning and MRI

Methanol appears to affect the basal ganglia, primarily the putamen. Because of the availability of advanced neuroimaging techniques, the putaminal damage tends to be detected much earlier in current practice than it was in the past.

CT scanning

Computed tomography (CT) scanning may reveal the characteristic changes of bilateral putaminal necrosis with varying degrees of hemorrhage, in addition to involvement of the cerebral white matter. However, the lesions may not be well localized when compared with magnetic resonance imaging (MRI) findings.

Moreover, often the initial CT scan is normal and several days may elapse before lesions become evident.

MRI

A characteristic finding is bilateral putaminal necrosis with or without hemorrhage, probably as a result of the direct toxic effects of methanol metabolites. This finding is certainly not specific for methanol toxicity, because it can be seen with other diseases, such as Wilson disease, Leigh disease, and stroke.[15]

Other findings that have been described include cerebral and intraventricular hemorrhage, diffuse cerebral edema, cerebellar necrosis, subcortical white matter necrosis, optic nerve necrosis, and even enhancement of necrotic lesions.[15]

In a series of 4 patients, MRI performed within 2 weeks of methanol intoxication demonstrated changes in the putamen of all 4 patients.[16] Three of these patients had white matter lesions within the occipital/frontal lobes. Interestingly, in patients who recovered without extrapyramidal symptoms, the lesions regressed within several weeks. The authors recommend MRI as a prognostic tool and as a means of differentiating methanol intoxication from other conditions, such as hypoglycemia and carbon monoxide poisoning.

Previous
 
 
Contributor Information and Disclosures
Author

Kalyani Korabathina, MD  Consulting Physician, North County Neurology Associates, Inc

Kalyani Korabathina, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society

Disclosure: Nothing to disclose.

Coauthor(s)

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

David Likosky, MD  Director of Stroke Program, President of Medical Staff, Evergreen Hospital Medical Center

David Likosky, MD is a member of the following medical societies: American Academy of Neurology, American College of Physicians-American Society of Internal Medicine, and American Heart Association

Disclosure: Nothing to disclose.

Chief Editor

Tarakad S Ramachandran, MBBS, FRCP(C), FACP  Professor of Neurology, Clinical Professor of Medicine, Clinical Professor of Family Medicine, Clinical Professor of Neurosurgery, State University of New York Upstate Medical University; Chair, Department of Neurology, Crouse Irving Memorial Hospital

Tarakad S Ramachandran, MBBS, FRCP(C), FACP is a member of the following medical societies: American Academy of Neurology, American Academy of Pain Medicine, American College of Forensic Examiners, American College of International Physicians, American College of Managed Care Medicine, American College of Physicians, American Heart Association, American Stroke Association, Royal College of Physicians, Royal College of Physicians and Surgeons of Canada, Royal College of Surgeons of England, and Royal Society of Medicine

Disclosure: Abbott Labs None None; Teva Marion None None; Boeringer-Ingelheim Honoraria Speaking and teaching

Additional Contributors

Nestor Galvez-Jimenez, MD, MSc, MHA Chairman, Department of Neurology, Program Director, Movement Disorders, Department of Neurology, Division of Medicine, Cleveland Clinic Florida

Nestor Galvez-Jimenez, MD, MSc, MHA is a member of the following medical societies: American Academy of Neurology, American College of Physicians, and Movement Disorders Society

Disclosure: Nothing to disclose.

Jonathan S Rutchik, MD, MPH Assistant Professor, Department of Occupational and Environmental Medicine, University of California at San Francisco

Jonathan S Rutchik, MD, MPH is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American College of Occupational and Environmental Medicine, and Society of Toxicology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Finkelstein Y, Vardi J. Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol. Neurotoxicology. Oct 2002;23(4-5):521-5. [Medline].

  2. Bitar ZI, Ashebu SD, Ahmed S. Methanol poisoning: diagnosis and management. A case report. Int J Clin Pract. Nov 2004;58(11):1042-4. [Medline].

  3. LeWitt PA, Martin SD. Dystonia and hypokinesis with putaminal necrosis after methanol intoxication. Clin Neuropharmacol. Apr 1988;11(2):161-7. [Medline].

  4. Coulter CV, Farquhar SE, McSherry CM, Isbister GK, Duffull SB. Methanol and ethylene glycol acute poisonings - predictors of mortality. Clin Toxicol (Phila). Dec 2011;49(10):900-6. [Medline].

  5. Rathi M, Sakhuja V, Jha V. Visual blurring and metabolic acidosis after ingestion of bootlegged alcohol. Hemodial Int. Jan 2006;10(1):8-14. [Medline].

  6. Casarett LJ, Doull J, Klaassen CD, eds. Casarett and Doull's Toxicology: The Basic Science of Poisons. 5th ed. New York, NY: McGraw-Hill; 1996:604-5, 756-7.

  7. Phang PT, Passerini L, Mielke B, et al. Brain hemorrhage associated with methanol poisoning. Crit Care Med. Feb 1988;16(2):137-40. [Medline].

  8. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol. 1997;35(2):127-43. [Medline].

  9. Rosenstock L, Cullen MR, eds. Textbook of Clinical Occupational and Environmental Medicine. Philadelphia, Pa: WB Saunders; 1994:768.

  10. Hageman G, van der Hoek J, van Hout M, et al. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol. Mar 1999;246(3):198-206. [Medline].

  11. Chio A, Herrero Hernandez E, Mora G, et al. Motor neuron disease and optic neuropathy after acute exposure to a methanol-containing solvent mixture. Amyotroph Lateral Scler Other Motor Neuron Disord. Sep 2004;5(3):188-91. [Medline].

  12. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. Sep-Oct 1986;1(5):309-34. [Medline].

  13. Fujita M, Tsuruta R, Wakatsuki J, et al. Methanol intoxication: differential diagnosis from anion gap-increased acidosis. Intern Med. Aug 2004;43(8):750-4. [Medline].

  14. McKellar MJ, Hidajat RR, Elder MJ. Acute ocular methanol toxicity: clinical and electrophysiological features. Aust N Z J Ophthalmol. Aug 1997;25(3):225-30. [Medline].

  15. Blanco M, Casado R, Vazquez F, Pumar JM. CT and MR imaging findings in methanol intoxication. AJNR Am J Neuroradiol. Feb 2006;27(2):452-4. [Medline].

  16. Hantson P, Duprez T, Mahieu P. Neurotoxicity to the basal ganglia shown by magnetic resonance imaging (MRI) following poisoning by methanol and other substances. J Toxicol Clin Toxicol. 1997;35(2):151-61. [Medline].

  17. LoVecchio F, Sawyers B, Thole D, et al. Outcomes following abuse of methanol-containing carburetor cleaners. Hum Exp Toxicol. Oct 2004;23(10):473-5. [Medline].

  18. Sharma R, Marasini S, Sharma AK, Shrestha JK, Nepal BP. Methanol Poisoning: Ocular and Neurological Manifestations. Optom Vis Sci. Nov 28 2011;[Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.